Financhill
Back

LENSAR Quote, Financials, Valuation and Earnings

LENSAR Price Quote

$7.77
+0.07 (+3.6%)
(Updated: December 21, 2024 at 5:35 AM ET)

LENSAR Key Stats

Buy
75
LENSAR (LNSR) is a Buy

Day range:
$7.35 - $7.88
52-week range:
$2.67 - $8.17
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.80
P/B ratio:
3.93%

Volume:
42.6K
Avg. volume:
48.3K
1-year change:
191.67%
Market cap:
$89.4M
Revenue:
$42.2M
EPS:
$-1.46

How Much Does LENSAR Make?

Data Unavailable

Is LENSAR Growing As A Company?

Data Unavailable

LENSAR Stock Price Performance

  • Did LENSAR Stock Go Up Last Month?
    LENSAR share price went up by 5.77% last month
  • Did LNSR's Share Price Rise Over The Last Year?
    LNSR share price rose by 191.67% over the past 1 year

What Is LENSAR 52-Week High & Low?

  • What Is LENSAR’s 52-Week High Share Price?
    LENSAR has traded as high as $8.17 over the past 52 weeks
  • What Is LENSAR’s 52-Week Low Share Price?
    LENSAR has traded as low as $2.67 over the past 52 weeks

LENSAR Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy LENSAR?

Data Unavailable

Is LENSAR Cash Flow Positive?

Data Unavailable

LENSAR Return On Invested Capital

Data Unavailable

LENSAR Earnings Date & Stock Price

  • What Is LENSAR's Stock Price Today?
    A single share of LNSR can be purchased today for 7.70
  • What Is LENSAR’s Stock Symbol?
    LENSAR trades on the nasdaq under the ticker symbol: LNSR
  • When Is LENSAR’s Next Earnings Date?
    The next quarterly earnings date for LENSAR is scheduled on March 4, 2025
  • When Is LNSR's next ex-dividend date?
    LENSAR's next ex-dividend date is December 22, 2024
  • How To Buy LENSAR Stock?
    You can buy LENSAR shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

LENSAR Competitors

  • Who Are LENSAR's Competitors?
    Below is a list of companies who compete with LENSAR or are related in some way:
    • Adagio Medical Holdings Inc (ADGM)
    • Ainos Inc (AIMD)
    • Intelligent Bio Solutions Inc (INBS)
    • Standard BioTools Inc (LAB)
    • Zomedica Corp (ZOM)

LENSAR Dividend Yield

Data Unavailable

LENSAR Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 68.1%
Revenue: 38.22% 17.73%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable